Compile Data Set for Download or QSAR
maximum 50k data
Found 108 with your filter
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538202(US11253521, No. 72)
Affinity DataIC50:  5.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538208(US11253521, No. 78)
Affinity DataIC50:  6.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538201(US11253521, No. 71)
Affinity DataIC50:  6.70nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Kalypsys

Curated by ChEMBL
LigandPNGBDBM50356505(CHEMBL1911882)
Affinity DataIC50:  7nMAssay Description:Inhibition of human iNOSMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538203(US11253521, No. 73)
Affinity DataIC50:  7.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538204(US11253521, No. 74)
Affinity DataIC50:  8.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538207(US11253521, No. 77)
Affinity DataIC50:  8.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538196(US11253521, No. 66)
Affinity DataIC50:  9.30nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538178(US11253521, No. 48)
Affinity DataIC50:  9.30nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538210(US11253521, No. 80)
Affinity DataIC50:  9.40nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538206(US11253521, No. 76)
Affinity DataIC50:  9.40nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538200(US11253521, No. 70)
Affinity DataIC50:  9.80nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538173(US11253521, No. 43)
Affinity DataIC50:  9.90nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538199(US11253521, No. 69)
Affinity DataIC50:  10nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
Kalypsys

Curated by ChEMBL
LigandPNGBDBM50356504(CHEMBL1911883)
Affinity DataIC50:  10nMAssay Description:Inhibition of human iNOSMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538174(US11253521, No. 44)
Affinity DataIC50:  10.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538153(US11253521, No. 23)
Affinity DataIC50:  11nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538180(US11253521, No. 50)
Affinity DataIC50:  11.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538205(US11253521, No. 75)
Affinity DataIC50:  11.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538187(US11253521, No. 57)
Affinity DataIC50:  12.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538188(US11253521, No. 58)
Affinity DataIC50:  12.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538176(US11253521, No. 46)
Affinity DataIC50:  12.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538171(US11253521, No. 41)
Affinity DataIC50:  13.3nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538183(US11253521, No. 53)
Affinity DataIC50:  13.7nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538175(US11253521, No. 45)
Affinity DataIC50:  14nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538189(US11253521, No. 59)
Affinity DataIC50:  14.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538162(US11253521, No. 32)
Affinity DataIC50:  14.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538186(US11253521, No. 56)
Affinity DataIC50:  14.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538194(US11253521, No. 64)
Affinity DataIC50:  14.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538170(US11253521, No. 40)
Affinity DataIC50:  15.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538177(US11253521, No. 47)
Affinity DataIC50:  15.7nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538190(US11253521, No. 60)
Affinity DataIC50:  16nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538185(US11253521, No. 55)
Affinity DataIC50:  16.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538172(US11253521, No. 42)
Affinity DataIC50:  16.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538209(US11253521, No. 79)
Affinity DataIC50:  16.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538191(US11253521, No. 61)
Affinity DataIC50:  16.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538193(US11253521, No. 63)
Affinity DataIC50:  16.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538195(US11253521, No. 65)
Affinity DataIC50:  17nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538197(US11253521, No. 67)
Affinity DataIC50:  17.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538184(US11253521, No. 54)
Affinity DataIC50:  18.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538211(US11253521, No. 81)
Affinity DataIC50:  18.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538181(US11253521, No. 51)
Affinity DataIC50:  19.2nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538165(US11253521, No. 35)
Affinity DataIC50:  19.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM50157853(5-Chloro-3-hydroxy-4a,8a-dihydro-1H-quinazoline-2,...)
Affinity DataIC50:  20.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538151(US11253521, No. 21)
Affinity DataIC50:  23.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538161(US11253521, No. 31)
Affinity DataIC50:  24.2nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538163(US11253521, No. 33)
Affinity DataIC50:  26.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538164(US11253521, No. 34)
Affinity DataIC50:  26.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538192(US11253521, No. 62)
Affinity DataIC50:  28.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFlap endonuclease 1(Homo sapiens (Human))
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538179(US11253521, No. 49)
Affinity DataIC50:  35.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 108 total ) | Next | Last >>
Jump to: